Brief Myth-buster · Sleep
Does melatonin help menopause sleep?
Probably not much. In a 2021 review that pooled randomized trials with 812 women in menopause, melatonin didn't improve sleep quality, hot flashes or mood1. In adults generally, it may help people fall asleep a little faster. But a sleep medicine guideline suggests not using it for chronic insomnia2, 3. CBT for insomnia has stronger evidence in women at midlife4.
What did the studies find?
The 2021 meta-analysis combined 8 groups of women in menopause from randomized trials that lasted 3 to 12 months1. Compared with the control groups, melatonin brought no clear improvement in sleep quality, overall menopause symptoms, hot flashes, anxiety or depression1. One score, for physical symptoms, did improve when 4 trials were pooled1. The authors said larger trials are needed to confirm their findings1.
Outside menopause, NCCIH reports that a 2022 review of 12 studies (2,666 people with insomnia) found melatonin helped people fall asleep faster and feel less sleepy in the day. It didn't improve sleep quality or time awake during the night2.
What do the experts say?
- The American Academy of Sleep Medicine (2017) suggests that clinicians not use melatonin for trouble falling or staying asleep. It's a weak recommendation, based on limited evidence3.
- NIH's complementary health center (NCCIH) notes that guidelines from 2017 and 2019 recommended against melatonin for chronic insomnia2.
- The Menopause Society (2023) lists supplements and herbal remedies under "not recommended" for hot flashes. It recommends cognitive behavioral therapy (Level I)5.
- ACOG's October 2026 guideline summary doesn't mention melatonin. It lists CBT among its non-drug options for hot flashes, sleep and mood symptoms6.
What has worked better in midlife women?
In a 2016 trial, 106 women aged 40 to 65 with insomnia and hot flashes had six phone sessions of CBT for insomnia (CBT-I) or menopause education. CBT-I eased insomnia more than menopause education did. At 8 weeks, 70% of the CBT-I group were in the no-insomnia range, compared with 24% of the education group4. Hot flashes didn't become less frequent, but they bothered women less4.
Is melatonin safe?
NCCIH says melatonin looks safe for most people in the short term, but long-term safety hasn't been established7. Reported side effects are mild, such as headache, dizziness, nausea and sleepiness. Melatonin can stay active longer in older people and cause daytime drowsiness7. Anyone taking medicine should check with a provider first, especially people with epilepsy or those taking blood thinners7.
In the US, melatonin is sold as a dietary supplement. The FDA regulates supplements less strictly than drugs and doesn't approve them for safety before they're sold7, 8. Labels can be off: NCCIH reports that in a 2023 test, 22 of 25 melatonin gummy products didn't contain the amount listed2.
The limitation
The menopause review included only 8 study groups that differed in design. Only 3 or 4 trials fed each result, and the authors called for larger trials1. The CBT-I trial was small and compared CBT-I with education, not with melatonin4.
One thing to try, one thing to ask
If you take melatonin, write it on your sleep record and the medicine list you bring to appointments. Our sleep path has a 2-week record. Then ask: "Could CBT for insomnia fit me, and is there a phone or online option?"
Sources
- Yi M, et al. Effects of exogenous melatonin on sleep quality and menopausal symptoms in menopausal women: a systematic review and meta-analysis of randomized controlled trials. Menopause. 2021. PMID 33784263. https://pubmed.ncbi.nlm.nih.gov/33784263/
- NCCIH. Sleep Disorders and Complementary Health Approaches (last updated May 2024). https://www.nccih.nih.gov/health/sleep-disorders-and-complementary-health-approaches
- Sateia MJ, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017. PMID 27998379. https://pubmed.ncbi.nlm.nih.gov/27998379/
- McCurry SM, et al. Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial. JAMA Intern Med. 2016. PMID 27213646. https://pubmed.ncbi.nlm.nih.gov/27213646/
- The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023. PMID 37252752. https://pubmed.ncbi.nlm.nih.gov/37252752/
- ACOG. ACOG Expands Recommendations for Management of Menopause Symptoms (news release), Oct 15, 2026. https://www.acog.org/news/2026/10/acog-expands-recommendations-for-management-of-menopause-symptoms/
- NCCIH. Melatonin: What You Need To Know (last updated May 2024). https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know
- US FDA. Questions and Answers on Dietary Supplements. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
Information for better conversations, not a diagnosis. This is research with sources, not medical advice. Talk to your clinician about your situation.